1. Home
  2. PEB vs MNKD Comparison

PEB vs MNKD Comparison

Compare PEB & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pebblebrook Hotel Trust of Beneficial Interest

PEB

Pebblebrook Hotel Trust of Beneficial Interest

N/A

Current Price

$12.21

Market Cap

1.5B

Sector

Real Estate

ML Signal

N/A

Logo MannKind Corporation

MNKD

MannKind Corporation

N/A

Current Price

$2.29

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PEB
MNKD
Founded
2009
1991
Country
United States
United States
Employees
60
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.7B
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
PEB
MNKD
Price
$12.21
$2.29
Analyst Decision
Hold
Buy
Analyst Count
10
7
Target Price
$12.60
$8.64
AVG Volume (30 Days)
2.1M
5.8M
Earning Date
04-28-2026
05-07-2026
Dividend Yield
0.33%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.02
Revenue
N/A
$348,966,000.00
Revenue This Year
N/A
$35.81
Revenue Next Year
$2.32
$11.89
P/E Ratio
N/A
$113.75
Revenue Growth
N/A
22.23
52 Week Low
$7.41
$2.23
52 Week High
$13.35
$6.51

Technical Indicators

Market Signals
Indicator
PEB
MNKD
Relative Strength Index (RSI) 49.40 22.10
Support Level $11.93 N/A
Resistance Level $12.80 $6.18
Average True Range (ATR) 0.42 0.13
MACD 0.00 0.06
Stochastic Oscillator 56.47 15.66

Price Performance

Historical Comparison
PEB
MNKD

About PEB Pebblebrook Hotel Trust of Beneficial Interest

Pebblebrook Hotel Trust currently owns upper upscale and luxury hotels with 11,933 rooms across 46 hotels in the United States. Pebblebrook acquired LaSalle Hotel Properties, which owned 10,451 rooms across 41 US hotels, in November 2018, though management has sold many of those hotels over the past few years. Pebblebrook's portfolio consists mostly of independent hotels with no brand affiliations, though the combined company does own and operate some hotels under Marriott, Starwood, InterContinental, Hilton, and Hyatt brands.

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

Share on Social Networks: